Strides Pharma share price rose 2.8% on the BSE, reaching an intraday high of ₹603 on Tuesday. The stock gained momentum after the company’s Singapore-based subsidiary, Strides Pharma Global, announced plans to acquire a 100% stake in Amexel Pte. Ltd. At 10:30 AM, Strides Pharma was trading 2.23% higher at ₹599.10, while the BSE Sensex …